CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value: $5.081M (100.0% shares, 0.0% debt)

Holdings (12)

RZLT REZOLUTE INC 75.3%

Value $3.825M Shares 1,318,967 Share Price $2.90 * Est. Cost/Share $9.52 Unrealized @ Report Date -54.3%

GLD SPDR GOLD TR 7.4%

Value $374K Shares 1,298 Share Price $288.21 Est. Cost/Share $246.72 Unrealized @ Report Date —

BRK/B BERKSHIRE HATHAWAY INC DEL 4.9%

Value $249K Shares 467 Share Price $532.80 * Est. Cost/Share $360.98 Unrealized @ Report Date +34.7%

— MIND MEDICINE MINDMED INC 3.9%

Value $199K Shares 34,073 Share Price $5.85 Est. Cost/Share $8.91 Unrealized @ Report Date —

BCAX BICARA THERAPEUTICS INC 2.8%

Value $143K Shares 10,941 Share Price $13.03 Est. Cost/Share $25.50 Unrealized @ Report Date -47.9%

CMPX COMPASS THERAPEUTICS INC 1.6%

Value $82,584 Shares 43,465 Share Price $1.90 * Est. Cost/Share $3.23 Unrealized @ Report Date -17.7%

LXEO LEXEO THERAPEUTICS INC 1.2%

Value $61,943 Shares 17,851 Share Price $3.47 * Est. Cost/Share $13.31 Unrealized @ Report Date -66.7%

KYTX KYVERNA THERAPEUTICS INC 0.9%

Value $44,354 Shares 22,981 Share Price $1.93 * Est. Cost/Share $23.94 Unrealized @ Report Date -87.7%

CRDF CARDIFF ONCOLOGY INC 0.8%

Value $41,721 Shares 13,287 Share Price $3.14 * Est. Cost/Share $3.13 Unrealized @ Report Date +26.5%

IKT INHIBIKASE THERAPEUTICS INC 0.7%

Value $35,901 Shares 16,393 Share Price $2.19 * Est. Cost/Share $2.49 Unrealized @ Report Date +0.7%

— ADICET BIO INC 0.3%

Value $13,203 Shares 17,488 Share Price $0.75 Est. Cost/Share $2.35 Unrealized @ Report Date —

CNTX CONTEXT THERAPEUTICS INC 0.2%

Value $11,263 Shares 18,403 Share Price $0.61 * Est. Cost/Share $1.72 Unrealized @ Report Date -49.5%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
RZLT	REZOLUTE INC	1,318,967	$3.825M	75.3%	$2.90 *	$9.52	-54.3%	COM NEW	76200L309
GLD	SPDR GOLD TR	1,298	$374K	7.4%	$288.21	$246.72	—	GOLD SHS	78463V107
BRK/B	BERKSHIRE HATHAWAY INC DEL	467	$249K	4.9%	$532.80 *	$360.98	+34.7%	CL B NEW	084670702
—	MIND MEDICINE MINDMED INC	34,073	$199K	3.9%	$5.85	$8.91	—	COM NEW	60255C885
BCAX	BICARA THERAPEUTICS INC	10,941	$143K	2.8%	$13.03	$25.50	-47.9%	COM	055477103
CMPX	COMPASS THERAPEUTICS INC	43,465	$82,584	1.6%	$1.90 *	$3.23	-17.7%	COM	20454B104
LXEO	LEXEO THERAPEUTICS INC	17,851	$61,943	1.2%	$3.47 *	$13.31	-66.7%	COM	52886X107
KYTX	KYVERNA THERAPEUTICS INC	22,981	$44,354	0.9%	$1.93 *	$23.94	-87.7%	COM	501976104
CRDF	CARDIFF ONCOLOGY INC	13,287	$41,721	0.8%	$3.14 *	$3.13	+26.5%	COM	14147L108
IKT	INHIBIKASE THERAPEUTICS INC	16,393	$35,901	0.7%	$2.19 *	$2.49	+0.7%	COM NEW	45719W205
—	ADICET BIO INC	17,488	$13,203	0.3%	$0.75	$2.35	—	COM	007002108
CNTX	CONTEXT THERAPEUTICS INC	18,403	$11,263	0.2%	$0.61 *	$1.72	-49.5%	COM	21077P108